ElectroCore’s Truvaga™ Plus Wins Men’s Health Magazine Tech Award
ElectroCore (Nasdaq: ECOR) has announced that its wellness product, Truvaga Plus, has received the Men's Health Magazine Tech Award. The award recognizes innovative wellness devices that make significant contributions to men's health and wellness. The product is designed to manage stress, enhance sleep, and improve mental focus. CEO Dan Goldberger expressed pride in receiving this prestigious recognition, emphasizing the company's dedication to developing life-improving solutions.
ElectroCore (Nasdaq: ECOR) ha annunciato che il suo prodotto per il benessere, Truvaga Plus, ha ricevuto il Men's Health Magazine Tech Award. Questo premio riconosce dispositivi innovativi per il benessere che apportano contributi significativi alla salute e al benessere maschile. Il prodotto è progettato per gestire lo stress, migliorare il sonno e aumentare la concentrazione mentale. Il CEO Dan Goldberger ha espresso orgoglio nel ricevere questo prestigioso riconoscimento, sottolineando la dedizione dell'azienda nello sviluppare soluzioni che migliorano la vita.
ElectroCore (Nasdaq: ECOR) ha anunciado que su producto de bienestar, Truvaga Plus, ha recibido el Men's Health Magazine Tech Award. Este premio reconoce dispositivos de bienestar innovadores que realizan contribuciones significativas a la salud y el bienestar masculino. El producto está diseñado para gestionar el estrés, mejorar el sueño y aumentar la concentración mental. El CEO Dan Goldberger expresó su orgullo por recibir este prestigioso reconocimiento, enfatizando la dedicación de la compañía al desarrollo de soluciones que mejoran la vida.
ElectroCore (Nasdaq: ECOR)는 웰빙 제품인 Truvaga Plus가 Men's Health Magazine Tech Award를 수상했다고 발표했습니다. 이 상은 남성 건강과 웰빙에 중요한 기여를 하는 혁신적인 웰빙 장치를 인정합니다. 이 제품은 스트레스를 관리하고, 수면을 개선하며, 정신적 집중력을 향상시키도록 설계되었습니다. CEO Dan Goldberger는 이 권위 있는 인정에 대한 자부심을 표명하며, 인생 개선 솔루션 개발에 대한 회사의 헌신을 강조했습니다.
ElectroCore (Nasdaq: ECOR) a annoncé que son produit de bien-être, Truvaga Plus, a reçu le Men's Health Magazine Tech Award. Ce prix reconnaît les dispositifs de bien-être innovants qui contribuent de manière significative à la santé et au bien-être masculins. Le produit est conçu pour gérer le stress, améliorer le sommeil et augmenter la concentration mentale. Le PDG Dan Goldberger a exprimé sa fierté de recevoir cette distinction prestigieuse, soulignant l'engagement de l'entreprise à développer des solutions améliorant la vie.
ElectroCore (Nasdaq: ECOR) hat angekündigt, dass sein Wellnessprodukt, Truvaga Plus, den Men's Health Magazine Tech Award erhalten hat. Der Preis erkennt innovative Wellnessgeräte an, die einen wesentlichen Beitrag zur Gesundheit und zum Wohlbefinden von Männern leisten. Das Produkt wurde entwickelt, um Stress zu bewältigen, den Schlaf zu verbessern und die mentale Konzentration zu steigern. CEO Dan Goldberger äußerte Stolz über diese prestigeträchtige Auszeichnung und betonte das Engagement des Unternehmens, lebensverbessernde Lösungen zu entwickeln.
- None.
- None.
ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness product, Truvaga Plus, has been awarded the prestigious Men’s Health Magazine Tech Award for a pioneering wellness device recognized for innovation and excellence. The award celebrates groundbreaking advancements in health and technology and highlights products that significantly impact men’s health and wellness. A link to the article can be found here: Men'sHealth Tech Awards 2025.
“We are honored to receive the Men’s Health Magazine Tech Award for Truvaga Plus,” said Dan Goldberger, CEO of ElectroCore. “This recognition underscores our commitment to developing solutions that improve quality of life by managing stress, enhancing sleep, and boosting mental focus. We are proud to have Truvaga Plus earn the recommendation from Men’s Health Magazine.”
About Men’s Health Magazine
Men’s Health Magazine, published by Hearst, is the world’s largest men’s magazine brand, offering up-to-date information and advice on every aspect of a man’s life, including health, fitness, fashion, and relationships. The magazine reaches a total audience of 21.8 million, including 13.7 million site visitors and 17.2 million social followers accessing trusted content through their digital platforms.
For more information, please visit www.menshealth.com
About Truvaga Plus
Truvaga Plus is a revolutionary handheld vagus nerve stimulator that utilizes the company’s proven technology to quickly and gently activate the vagus nerve. It’s designed to work with the body to balance the nervous system to feel calmer, think clearer, and sleep better. Truvaga Plus is intended for general health and wellness purposes only and is not intended to diagnose, cure, mitigate, treat, or prevent any disease.
For more information, please visit www.truvaga.com
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health and promoting general wellness through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. The company’s is focused on the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Forward-Looking Statements
This press release and other written and oral statements made by representatives of electroCore may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about electroCore's business prospects, new and existing wellness product offerings, new ecommerce site, and clinical and product development plans; its pipeline or potential markets for its technologies; the timing, outcome and impact of regulatory, clinical and commercial developments including focus group study results; the Company’s business prospects in the United States (including its e-commerce initiatives) and other new markets and other statements that are not historical in nature, particularly those that utilize terminology such as "anticipates," "will," "expects," "believes," "intends," other words of similar meaning, derivations of such words and the use of future dates. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the ability to raise the additional funding needed to continue to pursue electroCore’s business and product development plans, the inherent uncertainties associated with developing new products or technologies, the ability to commercialize gammaCore™, the ability to successfully launch and commercialize Truvaga Plus, the potential impact and effects of COVID-19 on the business of electroCore, electroCore’s results of operations and financial performance, and any measures electroCore has and may take in response to COVID-19 and any expectations electroCore may have with respect thereto, competition in the industry in which electroCore operates and overall market conditions. Any forward-looking statements are made as of the date of this press release, and electroCore assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents electroCore files with the SEC available at www.sec.gov.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
What award did ElectroCore's Truvaga Plus receive in November 2024?
What are the main benefits of ElectroCore's (ECOR) Truvaga Plus device?
When did ElectroCore (ECOR) win the Men's Health Magazine Tech Award?
What type of company is ElectroCore (ECOR)?
